https://www.biospace.com/cerevel-therapeutics-initiates-phase-1b-clinical-trial-of-cvl-231-a-m4-selective-positive-allosteric-modulator-in-development-for-the-treatment-of-schizophrenia
Cerevel Therapeutics Initiates Phase 1b Clinical Trial of CVL-231, a M4 Selective Positive...
Oct 22, 2019 - Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today it has dosed the first...
https://www.einpresswire.com/article/815214842/rosen-leading-investor-counsel-encourages-cerevel-therapeutics-holdings-inc-investors-to-secure-counsel-before-important-deadline-in-securities
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure...
May 22, 2025 - WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that (1) sold or otherwise disposed of the publicly-traded common stock of
cerevel therapeutics
https://robinhood.com/us/en/stocks/CERE/
Cerevel Therapeutics: CERE Stock Price Quote & News | Robinhood
You can watch CERE and buy and sell other stocks, ETFs, and their options commission-free on Robinhood. Change the date range, see whether others are buying or...
cerevel therapeuticsstock pricequotenewsrobinhood
https://remoteok.com/remote-jobs/remote-specialist-ii-research-operations-cerevel-therapeutics-530703
Remote Specialist II Research Operations at Cerevel Therapeutics
Cerevel Therapeutics is hiring a Remote Specialist II Research Operations. Company OverviewCerevel Therapeutics is dedicated to unraveling the mysteries of the...
research operationsremotespecialistiicerevel
https://en.wikipedia.org/wiki/Cerevel_Therapeutics
Cerevel Therapeutics - Wikipedia
cerevel therapeuticswikipedia
https://www.biospace.com/cerevel-therapeutics-to-present-at-the-evercore-isi-3rd-annual-healthconx-virtual-conference
Cerevel Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference -...
Nov 23, 2020 - Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced Chairperson and...
https://www.fool.com/investing/2021/07/19/why-cerevel-therapeutics-is-up-more-than-29-in-the/
Why Cerevel Therapeutics Is Up More Than 29% in the First Half of 2021 | The Motley Fool
Jul 19, 2021 - A positive early stage trial for a schizophrenia drug has pushed this biotech's stock this year.